CFS balanced superannuation funds have dominated the first quarter returns of 2021 with the top performing fund returning 4.5%, according to data.
FE Analytics data found CFS FirstChoice Multi-Index Moderate was the top performer, followed by CFS FC WS PersonalSuper FirstChoice Multi-Index Moderate (4.44%), and CFS FC PersonalSuper FirstChoice Multi-Index Moderate (4.39%).
Responsibly invested AMP SuperLeader AMP Responsible Investment Leaders Balanced (now called AMP Capital Ethical Leaders Balanced) followed at 3.75%, and ANZ Smart Choice Super Legg Mason Diversified at 3.74%.
The sector average for the three months to 31 March, 2021, was 2%.
Top performing balanced superannuation funds during Q1 2021
Source: FE Analytics
On the other end of the scale, there was only one fund that lost returns – AXA Flexible Income Plan Matched Portfolio lost 0.67%.
Over the longer-term, it was AMP SIGS MySuper Macquarie Balanced Growth that performed the best at 52.95% over the five years to 31 March, 2021.
Two CareSuper funds followed – CareSuper Balanced and CareSuper Sustainable Balanced – at 51.91% and 51.76% respectively, and Australian Ethical Balanced Accumulation at 50.96% and AMP SignatureSuper Macquarie Balanced Growth at 50.18%.
The sector average over the five years at 32.25%.
Top performing balanced superannuation funds over the five years to 31 March 2021
Source: FE Analytics
A member of the super fund has approached ASIC to investigate potentially misleading or deceptive representations by UniSuper regarding the holdings of its sustainable portfolios.
The median growth fund delivered 1.9 per cent in March, adding to the “stunning” rally that has seen super funds gain 11 per cent since November.
Vanguard has affirmed its support for the current super performance test, emphasising the importance of keeping the process straightforward.
While some superannuation funds have gone down the route of internalisation, others say they favour ‘smart partnering’ with external managers for diversification appeal.
Add new comment